Lower-middle income (World Bank) vs Oman: Pneumococcal conjugate second or third-dose vaccines (PCVc)

Lower-middle income (World Bank)
81.0%
in 2025
Oman
99.0%
in 2025
Lower-middle income (World Bank) rank
4th
Oman rank
1st

Pneumococcal conjugate second or third-dose vaccines (PCVc) over time

  • Lower-middle income (World Bank)
  • Oman
020406080100200820162025

How they compare

Oman currently reports 99.0% against 81.0% in Lower-middle income (World Bank), a difference of 18.0%.

That makes Oman's figure about 1.2 times Lower-middle income (World Bank)'s.

Across all 18 years both countries report, Oman has been ahead every year.

Lower-middle income (World Bank) ranks 4th and Oman ranks 1st of 11 groups.

Oman has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Lower-middle income (World Bank) Oman Difference Ahead
2000s 0.0% 48.0% 48.0% Oman
2010s 24.9% 98.8% 73.9% Oman
2020s 68.0% 98.7% 30.7% Oman

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Lower-middle income (World Bank) or Oman?
Oman, at 99.0% against 81.0% in Lower-middle income (World Bank) as of 2025.
What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Lower-middle income (World Bank) and Oman?
18.0%, with Oman ahead.
How many years of comparable data are there for Lower-middle income (World Bank) and Oman?
18 years are reported by both, from 2008 to 2025.
How do Lower-middle income (World Bank) and Oman rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
Lower-middle income (World Bank) ranks 4th and Oman ranks 1st of 11 groups.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Lower-middle income (World Bank) vs Oman: Pneumococcal conjugate second or third-dose vaccines (PCVc). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 30 August 2026, from https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/lower-middle-income-world-bank/oman/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/lower-middle-income-world-bank/oman/">Lower-middle income (World Bank) vs Oman: Pneumococcal conjugate second or third-dose vaccines (PCVc)</a> — Statizoid

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
206 places, 3,705 data points, 2008–2025
Last refreshed